CD177 and alkaline phosphatase measurement: In summary, our study confirmed that CD177 can predict AP with MODS, and that the exogenous supplementation of rhCD177 can improve inflammatory injury and prevent NET formation both in vitro and in vivo, providing several clinical intervention targets.